
Results
4
Big ticket companies showing a potential underpricing based on intrinsic value
4 companies
AstraZeneca
Market Cap: UK£204.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£132.00
7D
-4.3%
1Y
22.0%
GSK
Market Cap: UK£78.2b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.58
7D
2.4%
1Y
31.8%
Haleon
Market Cap: UK£29.7b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.35
7D
1.2%
1Y
-14.3%
Hikma Pharmaceuticals
Market Cap: UK£3.1b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£14.67
7D
0.3%
1Y
-30.1%